Therapeutic Asset Ratings

3,186 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes Malignant Glioma	City of Hope Medical Center	P1	D (16)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes Grade III Glioma	City of Hope Medical Center	P1	D (16)
Hucart-Meso Cells Ovarian Serous Adenocarcinoma	University of Pennsylvania	P1	D (16)
Senl101 T-Cell Non-Hodgkin Lymphoma	Hebei Senlang Biotechnology Inc., Ltd.	P1	D (16)
Senl101 T-Cell Acute Lymphoblastic Leukemia	Hebei Senlang Biotechnology Inc., Ltd.	P1	D (16)
Wu-Cart-007 Anaplastic Large Cell Lymphoma	Washington University School of Medicine	P1	D (16)
Wu-Cart-007 Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Washington University School of Medicine	P1	D (16)
Wu-Cart-007 Sezary Syndrome	Washington University School of Medicine	P1	D (16)
Wu-Cart-007 T-Cell Non-Hodgkin Lymphoma	Washington University School of Medicine	P1	D (16)
Anti-Car-Nk Cells Cancer	Wuxi People's Hospital	Early P1	D (16)
Anti Cd30 Car-T Cell Extranodal Nasal NK/T Cell Lymphoma	Zhejiang University	Early P1	D (16)
Bcma Car T Cells B-Cell Non-Hodgkin Lymphoma	Shanghai Cell Therapy Group Co.,Ltd	Early P1	D (16)
Bcma Car T Cells POEMS Syndrome	Zhejiang University	Early P1	D (16)
Bcma Targeted Car T-Cells Chronic Inflammatory Demyelinating Polyradiculoneuropathy	Tongji Hospital	Early P1	D (16)
Bcma Targeted Car T-Cells Myasthenia Gravis	Tongji Hospital	Early P1	D (16)
her2bbζ/cd19t+ t cells Sjogren Syndrome	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	Early P1	D (16)
Target Cd7 Car-T Cells T-Cell Acute Lymphoblastic Leukemia	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China	Early P1	D (16)
Universal Bcma Car-T Chronic Inflammatory Demyelinating Polyradiculoneuropathy	Xuanwu Hospital, Beijing	Early P1	D (16)
Universal Bcma Car-T Myasthenia Gravis	Xuanwu Hospital, Beijing	Early P1	D (16)
Anti-Cd30-Car-Transduced T Cells Leukemia	Affiliated Hospital of Nantong University	P1/2	D (16)
Autologous Cd33/Cd123 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	D (16)
Autologous Cd33/Cll1 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	D (16)
Autologous Cd5/Cd7 Dual-Target Car-T Module T-Cell Acute Lymphoblastic Leukemia	Beijing Biotech	P1/2	D (16)
Autologous Cd5/Cd7 Dual-Target Car-T Module Plasma Cell Myeloma	Beijing Biotech	P1/2	D (16)

Showing 3001 to 3025 of 3,186 assets

PreviousPage 121 of 128Next